More health-care analysts are defending managed-care companies after Democrats’ new “Medicare for all” bill spooked investors Feb. 27, sending shares of health insurers to their lowest in a month.
Most agree that the bill has almost no chance of passing in the current Congress, with Veda Partners’ Spencer Perlman calling it “an impossible dream.” Analysts said the market’s response was an overreaction and recommended that investors to buy shares on weakness. However, JPMorgan’s Gary Taylor cautioned that it may take some time for insurance stocks to recover.
Here’s what analysts are saying:
JPMorgan, Gary Taylor
“The bill has no...